Gland Pharma Limited: management transactions · India · SEBI (PIT + SAST) SEBI:gland-pharma-limited IN IN · SEBI (PIT + SAST) Mcap 262.4Bn€
Browse the full management transaction log of Gland Pharma Limited, a publicly traded company based in India. Shares trade on IN IN, under the authority of SEBI (PIT + SAST). Market capitalisation: €262.4bn. The latest transaction was disclosed on 9 February 2026 — Sale. Among the most active insiders: A RENUKA DEVI. All data is openly available.
Financial data FY ended March 2025 · cache
Income statement
Revenue 55.84 Bn€
Gross profit 34.93 Bn€ 63% margin
Net income 6.99 Bn€ 12.5% margin
Balance sheet & cash
Market cap 262.36 Bn€
Total debt 3.14 Bn€
Free Cash Flow 5.21 Bn€
Last declaration on 9 February 2026
Declarations 467 total
Executives ● Sale0 SEBI
€1,766 100 shares @ €17.6604
Equity Shares
SEBI:64359e729f8a302301bcd50e60e0d7e8dc054fa1 · 9 Feb 2026
Executives ● Sale0 SEBI
€5,380 306 shares @ €17.5825
Equity Shares
SEBI:a7470f85ea5c6822c8e9c1f8f1ee31cdca30f082 · 2 Feb 2026
Executives ● Sale0 SEBI
€13,620 800 shares @ €17.0244
Equity Shares
SEBI:9284d4fc50f86c7355e1f6ad615e41666665dda4 · 2 Feb 2026
Executives ● Sale0 SEBI
€5,282 300 shares @ €17.6081
Equity Shares
SEBI:0c553b126afc4d153b330c6987a647a0162b3bca · 21 Nov 2025
Executives ● Sale0 SEBI
€3,667 191 shares @ €19.1968
Equity Shares
SEBI:efc2c4d3c37b3f46d910f3dd4bbb5fc27e56bf0c · 26 Sept 2025
Executives ● Sale0 SEBI
€6,308 325 shares @ €19.4099
Equity Shares
SEBI:e305c9683f76f7bbfe0369f272f40191c57a5a4d · 23 Sept 2025
Executives ● Purchase0 SEBI
€16,540 2,800 shares @ €5.9073
Equity Shares
SEBI:7219b733f3d9d15f3f9020dbc6a9bb12c9ff8b1e · 26 Feb 2025
Ideal exit: 23 Nov 2025 (T+270) Executives ● Sale0 SEBI
€28,294 1,400 shares @ €20.21
Equity Shares
SEBI:e4ea85dcb0fbf1867d673db8b6c041386654c0fb · 27 Jun 2024
Executives ● Sale0 SEBI
€115,966 5,792 shares @ €20.0217
Equity Shares
SEBI:05fbfdc56e93e783b07fc37fd92ccc9856377084 · 26 Jun 2024
Executives ● Sale0 SEBI
€39,456 1,950 shares @ €20.234
Equity Shares
SEBI:7bc39ca3abd0d376443a649a5493d36dee74d5d6 · 27 Jun 2024
Executives ● Sale0 SEBI
€39,506 1,950 shares @ €20.2595
Equity Shares
SEBI:f0701641538c4b901e0b3a0d1fe4eb2e3ab8f5aa · 27 Jun 2024
Executives ● Sale0 SEBI
€19,699 968 shares @ €20.3506
Equity Shares
SEBI:360d722842482602528dacf731d13346b3e39d4e · 24 Jun 2024
Executives ● Sale0 SEBI
€40,823 2,000 shares @ €20.4117
Equity Shares
SEBI:8f689a3055a3a2f0dd127b874064687d16ce52f3 · 25 Jun 2024
Executives ● Sale0 SEBI
€125,863 6,182 shares @ €20.3595
Equity Shares
SEBI:f5df3c409187d16ba48415623ef990eb2e880bdf · 25 Jun 2024
Executives ● Sale0 SEBI
€20,379 1,000 shares @ €20.3791
Equity Shares
SEBI:225d8f1f09305affbbab911ef21fc9afb4ad2b81 · 25 Jun 2024
Executives ● Sale0 SEBI
€81,402 4,000 shares @ €20.3506
Equity Shares
SEBI:a10a415c9823cb6c91b3f02c9247f4863b964dfe · 24 Jun 2024
Executives ● Sale0 SEBI
€45,725 2,250 shares @ €20.3221
Equity Shares
SEBI:fca8aec1909c14d829cd7cd4f7382df7f7ad6e0c · 24 Jun 2024
Executives ● Sale0 SEBI
€20,351 1,000 shares @ €20.3506
Equity Shares
SEBI:8b69af0f66e683207b9cbbeea8ecb5fd725d2aac · 24 Jun 2024
Executives ● Sale0 SEBI
€61,018 3,000 shares @ €20.3394
Equity Shares
SEBI:37ea413e40144ed1db5e0c5b8a35488f5749ef0a · 24 Jun 2024
Executives ● Sale0 SEBI
€30,526 1,500 shares @ €20.3506
Equity Shares
SEBI:4d69956893fe3cff5de43217e94ab6ce1bfb7204 · 24 Jun 2024
Executives ● Sale0 SEBI
€10,131 500 shares @ €20.262
Equity Shares
SEBI:605952386b5df2383e2f901adac2a3a3386e1487 · 24 Jun 2024
Executives ● Sale0 SEBI
€264,962 13,000 shares @ €20.3817
Equity Shares
SEBI:3b73e8629777115c75d3c67c9e4c64c26cb49676 · 20 Jun 2024
Executives ● Sale0 SEBI
€195m 9,900,000 shares @ €19.7398
Equity Shares
SEBI:688ec1d79533f8224a9bc66e2dd67a92b03ebb0f · 19 Jun 2024
Executives ● Sale0 SEBI
€30,565 1,456 shares @ €20.9922
Equity Shares
SEBI:4bb344bcfd94def6e2201a382528b42d88c9f3e7 · 10 Jun 2024
Executives ● Purchase0 SEBI
€13,699 2,300 shares @ €5.956
Equity Shares
SEBI:6710fced2371828d707cf7c9e688dfd817c03524 · 7 Jun 2024
Ideal exit: 4 Mar 2025 (T+270) 25 of 467 declarations
Load more (442 remaining) About Gland Pharma Limited Gland Pharma Limited is an Indian pharmaceutical company specializing in the manufacture of injectable products. It is listed on the Bombay Stock Exchange.